glp-1 and ckd Glucagon-like peptide-1 receptor agonists in diabetic kidney disease: A review of their kidney heart protection KDIGO Guidelines on Diabetes and

GLP-1 drugs are remarkably effective at reducing visceral fat, which accumulates around the waist, surrounding and invading the liver, heart, and pancreas

Nasseri MD to Learn How Semaglutide GLP-1 Works to Help You Lose Weight and Keep It Off.

Genetics play a role in canker sore development

SCFAs mediate systemic antioxidant responses via gut-organ axis communication, while EVs ameliorate intestinal barrier dysfunction through MAPK signaling pathway modulation

ESG has been shown to influence metabolic pathways, as demonstrated in the MERIT study (The Lancet, 2022), suggesting may offer similar metabolic benefits as a manual ESG approach